You are here

Interviews

21.02.2011

Dra. Marta Príncep

Biocat director of Innovation

15.03.2011

Dra. Magda Rafecas

professor of Nutrition and Bromatology, University of Barcelona

21.04.2011

Ralph Klingmann

CEO of Omnia Molecular

He joined Omnia Molecular as CEO after raising €2.1 million Investment Round in 2010. Swiss/German national. Molecular Biologist (USA) and Global Executive MBA (Spain-IESE). 20 years international pharma leadership in USA, Germany and South Africa with Bayer, Solvay and Abbott.

21.07.2011

Dr. Joan de Pablo i Dra. Irene Jubany

Dr. Joan de Pablo, chemical engineering chair and scientific director of the CTM Technology Center Foundation Environmental Technology Department. Dr. Irene Jubany, researcher and head of Soil for the CTM Technology Center Foundation Environmental Technology Department. Both participated in the workshop organized by Biocat, on 8 June, in Barcelona.

24.10.2011

Dra. Montserrat Vendrell

CEO of Biocat

11.11.2011

Dr. Juan Martín-Caballero

 director of the Department of Animal Models at the PRBB

14.12.2011

Dr. Valentí Fuster

 director of the Cardiovascular Institute at Mount Sinai Hospital in New York and the Carlos III National Center for Cardiovascular Research in Madrid

10.01.2012

Inez de Beaufort

professor of Health Care Ethics at the Erasmus Medical Center of Rotterdam

professor of Health Care Ethics at the Erasmus Medical Center of Rotterdam. Speaker at the lecture series Culture and Life. Dialogues on the Impact of Biotechnology organized by the International Center for Scientific Debate (ICSD) and the Centre de Cultura Contemporània de Barcelona (CCCB)

Manel Esteller
15.02.2012

Dr. Manel Esteller

Dr. Manel Esteller, ICREA research professor, head of the Cancer Epigenetics and Biology Program at the Biomedical Research Institute of Bellvitge (IDIBELL) and professor of genetics at the University of Barcelona

01.03.2012

Josep M. Canals

coordinator of the Cell Therapy Program (TCUB) of the University of Barcelona Faculty of Medicine. He spoke at the workshop "Challenges and Risks of Research in Advanced Therapies" organized by Biocat and the TCUB on 20 January 2012 in Barcelona.